Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome 26S subunit non-ATPase 4 (PSMD4), also known as Rpn10 or S5a, is an essential non-ATPase subunit of the 19S regulatory particle of the 26S proteasome. It functions primarily as a ubiquitin receptor, utilizing its ubiquitin-interacting motifs (UIMs) to recognize and bind polyubiquitinated proteins, thereby facilitating their delivery to the 20S core particle for degradation. PSMD4 plays a critical role in maintaining cellular protein homeostasis, regulating the cell cycle, apoptosis, and antigen presentation. In disease states, PSMD4 is frequently overexpressed in various malignancies, such as multiple myeloma, hepatocellular carcinoma, and colorectal cancer, where it promotes tumor cell survival and contributes to chemoresistance. Conversely, its dysregulation is also implicated in neurodegenerative disorders due to the accumulation of toxic protein aggregates. Therapeutic targeting of PSMD4, such as with the small-molecule inhibitor SB699551, represents a promising strategy to selectively induce apoptosis in cancer cells and overcome resistance to traditional proteasome inhibitors without directly blocking the catalytic activity of the 20S core.
Inhibition of ubiquitin receptor function by blocking the binding of polyubiquitinated proteins to the 19S regulatory particle, thereby preventing substrate delivery to the 20S catalytic core.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 26S proteasome non-ATPase regulatory subunit 4 (PSMD4).